scholarly journals Long‐term efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 5‐year extension of a phase 3 study (reSURFACE 1)

2021 ◽  
Author(s):  
Shinichi Imafuku ◽  
Hidemi Nakagawa ◽  
Atsuyuki Igarashi ◽  
Akimichi Morita ◽  
Yukari Okubo ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Japanese Patients ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Severe Plaque Psoriasis ◽  
Term Efficacy

scholarly journals Long-term efficacy and safety of secukinumab in Japanese patients with moderate to severe plaque psoriasis: 3-year results of a double-blind extension study

2019 ◽  
Vol 46 (3) ◽  
pp. 186-192 ◽  
Author(s):  
Yukari Okubo ◽  
Mamitaro Ohtsuki ◽  
Akimichi Morita ◽  
Masako Yamaguchi ◽  
Tomohiro Shima ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Japanese Patients ◽  
Extension Study ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Severe Plaque Psoriasis ◽  
Term Efficacy

scholarly journals Efficacy and safety of ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis: Subgroup analysis of a placebo-controlled, phase 3 study (UNCOVER-1)

2017 ◽  
Vol 44 (11) ◽  
pp. 1285-1290 ◽  
Author(s):  
Shinichi Imafuku ◽  
Hitoe Torisu-Itakura ◽  
Atsushi Nishikawa ◽  
Fangyi Zhao ◽  
Gregory S. Cameron ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Subgroup Analysis ◽  
Japanese Patients ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Severe Plaque Psoriasis

Secukinumab efficacy and safety in Japanese patients with moderate-to-severe plaque psoriasis: Subanalysis from ERASURE, a randomized, placebo-controlled, phase 3 study

2014 ◽  
Vol 41 (12) ◽  
pp. 1039-1046 ◽  
Author(s):  
Mamitaro Ohtsuki ◽  
Akimichi Morita ◽  
Masatoshi Abe ◽  
Hidetoshi Takahashi ◽  
Noriko Seko ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Japanese Patients ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Severe Plaque Psoriasis

Long-term Efficacy and Safety of Brodalumab in Patients With Psoriasis Disease Duration <10 and ≥10 Years: Analysis of Two Phase 3 Studies

2019 ◽  
Vol 3 ◽  
pp. S25
Author(s):  
Benjamin Ehst ◽  
George Han ◽  
Scott Guenthner ◽  
Kimberly Eads ◽  
Abby Jacobson
Keyword(s):  
Disease Duration ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Two Phase ◽  
Term Efficacy

Abstract not available.

Sign in / Sign up

Export Citation Format

Share Document